🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.🔸Stay tuned for more insights from the late-...
🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General Practitioner.🔸Stay tuned for more insights from the...